HomeNewsBusinessStocksInvestment tips: Analysts tell you how to play 7 key stocks

Investment tips: Analysts tell you how to play 7 key stocks

Goldman Sachs reiterates buy on Maruti with target revised to Rs 5774 from Rs 4923 per share. It has raises FY17-18 EPS by 3.5 percent to 4.4 percent on the back of a weaker yen. Moderation is expected in marketing spend post 61 percent surge in FY16 led by Nexa.

September 06, 2016 / 14:08 IST
Story continues below Advertisement

Here are brokerage firms' views on seven stocks.

Jubilant Foodworks JP Morgan is overweight with target of Rs 1210 per share. It says key disappointment was negative same-store-sales growth  SSSG growth of negative 3.2 percent. Its management expects improved performance in Q2 and positive SSSG.Deutsche Bank has a hold call with a target of Rs 1350 per share. It says SSSG of  negative 3.2 percent  raises questions about permanent consumer behaviour changes. It expects stock to stay volatile and continue underperformance. It says  its company’s  ability to call business turnaround has been poor. Maruti Goldman Sachs reiterates buy with target revised to Rs 5774 from Rs 4923 per share. It has raises FY17-18 EPS by 3.5 percent to 4.4 percent on the back of a weaker yen. Moderation is expected in marketing spend post 61 percent surge in FY16 led by Nexa. It says full benefits of mix improvement will play out in the latter half of FY18. Maruti’s domestic market share at 48 percent is close to its 10-year highs.

Story continues below Advertisement

Tata MotorsJP Morgan is overweight with a target of Rs 570 per share. Its new models are driving growth in JLR & India. Morgan Stanley is overweight with target at Rs 585 per share. It expects continued strong sales in us in second half  as new model cycle plays out.

MindtreeMorgan Stanley downgrades it to underweight from overweight and cut target to Rs 455 from Rs 670 per share. It says Q2 warning indicates business predictability has fallen and macro risks increasing faster than expected. Macro risks, concentrated exposure & Bluefin weakness should drag growth. It has also cut revenue target by 4-9 percent and margin by 160 basis points and EPS by 17-20 percent for FY17-19.